BioCentury
ARTICLE | Clinical News

TactiCath: Pivotal trial started

January 24, 2011 8:00 AM UTC

EndoSense began the U.S. and European pivotal TOCCASTAR trial to compare its TactiCath force-sensing ablation catheter vs. an undisclosed FDA-approved catheter in 300 patients. The product has CE Mark...